TR199901796A2 - Kinolon ve naftiridon karboksilik asit hazirlama usulü. - Google Patents

Kinolon ve naftiridon karboksilik asit hazirlama usulü.

Info

Publication number
TR199901796A2
TR199901796A2 TR1999/01796A TR9901796A TR199901796A2 TR 199901796 A2 TR199901796 A2 TR 199901796A2 TR 1999/01796 A TR1999/01796 A TR 1999/01796A TR 9901796 A TR9901796 A TR 9901796A TR 199901796 A2 TR199901796 A2 TR 199901796A2
Authority
TR
Turkey
Prior art keywords
quinolone
carboxylic acid
acid preparation
naphthyridone carboxylic
naphthyridone
Prior art date
Application number
TR1999/01796A
Other languages
English (en)
Inventor
Norris Timothy
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of TR199901796A2 publication Critical patent/TR199901796A2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

7-yedegine bagli dissal amino grubuna sahip dis amino grup üzerindeki blokaj gruplarinin kullanimina ve çikarilamsina gerek kalmadan hazirlanan antibakteriel kinolon karboksilik asitler ve naftridon karboksilik asitler.
TR1999/01796A 1998-07-28 1999-07-28 Kinolon ve naftiridon karboksilik asit hazirlama usulü. TR199901796A2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9444098P 1998-07-28 1998-07-28

Publications (1)

Publication Number Publication Date
TR199901796A2 true TR199901796A2 (tr) 2000-02-21

Family

ID=22245218

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/01796A TR199901796A2 (tr) 1998-07-28 1999-07-28 Kinolon ve naftiridon karboksilik asit hazirlama usulü.

Country Status (17)

Country Link
US (1) US6114531A (tr)
EP (1) EP0976749A1 (tr)
JP (1) JP2000053646A (tr)
KR (1) KR100343356B1 (tr)
CN (1) CN1247865A (tr)
AR (1) AR019936A1 (tr)
AU (1) AU4116999A (tr)
BR (1) BR9903003A (tr)
CA (1) CA2278845C (tr)
HU (1) HUP9902548A3 (tr)
ID (1) ID25767A (tr)
IL (1) IL131040A0 (tr)
PL (1) PL334621A1 (tr)
RU (1) RU2167867C2 (tr)
TR (1) TR199901796A2 (tr)
YU (1) YU35599A (tr)
ZA (1) ZA994814B (tr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6239141B1 (en) * 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions
CN1297542C (zh) * 2003-12-28 2007-01-31 柯保桂 6－氟－1，4－二氢－4－氧代喹啉－3－羧酸衍生物的制备
CN1244582C (zh) * 2004-04-21 2006-03-08 中国医学科学院医药生物技术研究所 喹诺酮羧酸类化合物及其制备方法和医药用途
US7759362B2 (en) * 2004-04-21 2010-07-20 Institut Of Medicinal Biotechnology Chinese Academy Of Medical Sciences Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof
US7902227B2 (en) * 2007-07-27 2011-03-08 Janssen Pharmaceutica Nv. C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU553415B2 (en) * 1983-09-19 1986-07-17 Abbott Japan Co., Ltd. 6-fluoro-1-4-dihydro-4-oxo-7-substituted piperazinyl- quinoline-3-carboxylic acids
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
EP0549857A1 (en) * 1991-12-31 1993-07-07 Korea Research Institute Of Chemical Technology Antibacterial quinolone carboxylic acid derivatives
AU704115B2 (en) * 1995-08-29 1999-04-15 Pfizer Inc. Zwitterionic forms of trovafloxacin
JPH09125546A (ja) * 1995-11-02 1997-05-13 Sekisui Chem Co Ltd 二重断熱部材
JPH09208578A (ja) * 1996-02-07 1997-08-12 Dainippon Pharmaceut Co Ltd ピリドンカルボン酸誘導体およびそれを有効成分とする抗ピロリ菌剤

Also Published As

Publication number Publication date
KR20000012002A (ko) 2000-02-25
PL334621A1 (en) 2000-01-31
CA2278845A1 (en) 2000-01-28
CN1247865A (zh) 2000-03-22
CA2278845C (en) 2003-07-08
AU4116999A (en) 2000-02-17
AR019936A1 (es) 2002-03-27
EP0976749A1 (en) 2000-02-02
ZA994814B (en) 2001-01-29
HUP9902548A2 (hu) 2000-05-28
US6114531A (en) 2000-09-05
YU35599A (sh) 2002-11-15
HU9902548D0 (en) 1999-10-28
RU2167867C2 (ru) 2001-05-27
HUP9902548A3 (en) 2001-01-29
ID25767A (id) 2000-11-02
BR9903003A (pt) 2000-03-21
KR100343356B1 (ko) 2002-07-15
IL131040A0 (en) 2001-01-28
JP2000053646A (ja) 2000-02-22

Similar Documents

Publication Publication Date Title
BR9508031A (pt) Composto antiviral composição farmacéutica ou veterinária e processo para o tratamento antiviral profilático ou terapéuitco de um humano ou animal náo humano e uso do composto
NZ227680A (en) Quinoline and naphthyridine derivatives, intermediates and pharmaceutical compositions
FI974440A0 (fi) Bifenyyli-2-karboksyylihappo-tetrahydro-isokinolin-6-yyli-amidijohdannaisia, niiden valmistus ja niiden käyttö mikrosomaalistatriglyseridiä siirtävän proteiinin ja/tai apolipoproteiini B:n (Apo B) erittymiseen inhibiittoreina
EP0266576A3 (en) 1-tert-alkyl-substituted naphthyridine and quinoline carboxylic acids as antibacterial agents
AU2482800A (en) Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors
HUP0200492A2 (hu) Eljárás retinoid bőrkárosodás gátlására
TR200101943T2 (tr) Bir immun cevap modifayeri ile mukoza ile ilgili durumların tedavisine yönelik formülasyonlar ve metodlar.
EE03741B1 (et) N-propargüül-1-aminoindaani R-enantiomeeri, sellesoolade ja kompositsioonide kasutamine
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
PT912564E (pt) Processo para preparar tetra-hidroimidazoquinolinaminas
EA200300375A1 (ru) Производные 2-амино-2-алкил-4-гексеновой и -гексиновой кислот, которые могут быть использованы в качестве ингибиторов синтетазы оксида азота
NO940039D0 (no) Chinolon- og naftyridonkarboksylsyrederivater
IE863104L (en) Quinolone derivatives
ATE260657T1 (de) Oral applizierbare formulierungen von chinolon- oder naphthyridoncarbonsäuren
TR200002248T2 (tr) Yeni dihidroksiheksanoik asit türevleri
NO863398D0 (no) Smaksmaskerende preparater.
SE9201930D0 (sv) Gastric antibacterial treatment
TR199901796A2 (tr) Kinolon ve naftiridon karboksilik asit hazirlama usulü.
NO931011L (no) 7-okso-7h-pyrido(1,2,3-de)(1,4)benzoksacin-6-karbonsyrer og -estere
DE3681127D1 (de) Primycin enthaltendes kolloidales grundgel, verfahren zu dessen herstellung, dieses grundgel enthaltende pharmazeutische und pharmako-kosmetische kompositionen.
FI945360A (fi) 1-(2-fluorisyklopropyyli)kinoloni- ja naftyridonikarboksyylihappojohdannaiset
IT9003728A0 (it) Sali di glicosaminoglicani con esteri di aminoacidi, loro preparazionee formulazioni farmaceutiche che li contengono.
TR28357A (tr) Karboksi-arensulfonik asitlerin ve bunlarin karbonik asit türevlerinin üretilmesine mahsus usul.
ES517596A0 (es) Procedimiento para la preparacion de un peptido.
FI953081A0 (fi) Sekviterpeenit, niiden valmistaminen ja niiden käyttö inhibiittoreina, jotka vaikuttavat GABA-bentsodiatsepiinireseptoriin